Adherence to omalizumab: a real-life study

被引：0
作者：
Campisi, Raffaele [1 ]
Crimi, Claudia [1 ]
Noto, Alberto [2 ]
Foschino, Maria Pia [3 ]
Valenti, Giuseppe [4 ]
Viviano, Vittorio [4 ]
Pelaia, Corrado [5 ]
Ricciardi, Luisa [6 ]
Scichilone, Nicola [7 ]
Crimi, Nunzio [8 ]
机构：
[1] AOU Policlin Vittorio Emanuele, Resp Med Unit, Catania, Italy
[2] AOU Policin G Martino, Anesthesia & Intens Care Unit, Messina, Italy
[3] Univ Foggia, Inst Resp Dis, Dept Med & Surg Sci, Foggia, Italy
[4] Ctr Individuato ASMA GRAVE, Ctr Riferimento Aziendale Terr Prevenz Malattie A, Palermo, Italy
[5] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy
[6] Univ Messina, Sch & Div Allergy & Clin Immunol, Dept Human Pathol, Messina, Italy
[7] Univ Palermo, Sez Pneumol, Dipartimento Biomed Med Interna & Specialist DIBI, Palermo, Italy
[8] Univ Catania, Resp Med Unit, Dept Clin & Expt Med, AOU Policlin Vittorio Emanuele, Catania, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; -; management; Quality of life; Adherence;
D O I：
10.1183/13993003.congress-2019.PA2525
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2525
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting
    Kralimarkova, Tanya
    Staevska, Maria
    Lazarova, Tsvetelina
    Hristova, Diana
    Dimitrov, Vasil
    Popov, Todor
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [22] Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation
    Benzimra, Michael
    Bonnamour, Beatrix
    Duracinsky, Martin
    Lalanne, Christophe
    Aubert, Jean-Pierre
    Chassany, Olivier
    Aubin-Auger, Isabelle
    Mahe, Isabelle
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 79 - 87
  • [23] Results of omalizumab treatment in chronic eosinophilic pneumonia: Real-life data
    Basa Akdogan, Buket
    Aksu, Kurtulus
    Koca Kalkan, Ilkay
    Koycu Buhari, Gozde
    Ozdedeoglu, Ozlem
    Ates, Hale
    Oner Erkekol, Ferda
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2024, 72 (01):
  • [24] Adherence to omalizumab: A multicenter "real-world" study
    Campisi, Raffaele
    Crimi, Claudia
    Intravaia, Rossella
    Strano, Simona
    Noto, Alberto
    Foschino, Maria Pia
    Valenti, Giuseppe
    Viviano, Vittorio
    Pelaia, Corrado
    Ricciardi, Luisa
    Scichilone, Nicola
    Crimi, Nunzio
    WORLD ALLERGY ORGANIZATION JOURNAL, 2020, 13 (02):
  • [25] Effectiveness of omalizumab in severe persistent asthma under real-life conditions
    D'Urzo, Anthony D.
    Wong, Jenny
    CANADIAN FAMILY PHYSICIAN, 2014, 60 (07) : 643 - 645
  • [26] Can omalizumab be an alternative treatment for non-atopic severe asthma? A real-life experience with omalizumab
    Ediger, Dane
    Günaydin, Fatma Esra
    Erbay, Muee
    Pekbak, Gulseren
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2023, 71 (01): : 24 - 33
  • [27] Treatment adherence: a hurdle for real-life effectiveness in psoriasis?
    Reich, K.
    Dauden, E.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 : 1 - 3
  • [28] The Real-Life Effectiveness and Safety of Omalizumab Updosing in Patients With Chronic Spontaneous Urticaria
    Salman, Andac
    Comert, Elif
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2019, 23 (05) : 496 - 500
  • [29] Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany
    Korn, S.
    Thielen, A.
    Seyfried, S.
    Taube, C.
    Kornmann, O.
    Buhl, R.
    RESPIRATORY MEDICINE, 2009, 103 (11) : 1725 - 1731
  • [30] The level of diagnostic assessment in severe asthma: A nationwide real-life study
    von Bulow, Anna
    Backer, Vibeke
    Bodtger, Uffe
    Soes-Petersen, Niels Ulrik
    Assing, Karin Dahl
    Skjold, Tina
    Porsbjerg, Celeste
    RESPIRATORY MEDICINE, 2017, 124 : 21 - 29
12345